Open Access

ARTICLE

Reversal of tamoxifen resistance by artemisinin in ER+ breast cancer: bioinformatics analysis and experimental validation

ZHILI ZHUO^#, DONGNI ZHANG^#, WENPING LU^*, XIAOQING WU, YONGJIA CUI, WEIXUAN ZHANG, MENGFAN ZHANG

Department of Oncology, China Academy of Chinese Medical Sciences Guang’anmen Hospital, Beijing, China

* Corresponding Author: WENPING LU. Email: